Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation

Journal of Clinical Oncology

Volumn 16, Issue 1, 1998, Pages 165-172

  Hesdorffer, Charles ^a   Ayello, Janet ^a   Ward, Maureen ^a   Kaubisch, Andreas ^a   Vahdat, Linda ^a   Balmaceda, Casilda ^a   Garrett, Tom ^a   Fetell, Michael ^a   Reiss, Robert ^a   Bank, Arthur ^a   Antman, Karen ^a  

^a College of Physicians and Surgeons of Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; CD34 ANTIGEN; GLYCOPROTEIN P; PACLITAXEL; PODOPHYLLIN; VINCA ALKALOID;

ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; AUTOTRANSPLANTATION; BONE MARROW CELL; BURST FORMING UNIT E; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COLONY FORMING UNIT GM; DRUG MEGADOSE; FEMALE; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HUMAN; MALE; MULTIDRUG RESISTANCE; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RETROVIRUS; SOLID TUMOR; STEM CELL TRANSPLANTATION;

EID: 0031972859     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.1.165     Document Type: Article

References (32)

1. Frei III E, Antman K, Teicher B, et al: Bone marrow autotransplantation for solid tumors - prospects. J Clin Oncol 7:515-526, 1989
2. Hryniak W, Bush H: The importance of dose intensity in chemotherapy of metastatic breast cancer. J Clin Oncol 2:1281-1288, 1984
3. DeVita VT, Hubbard SM, Young RC, et al: The role of chemotherapy in diffuse aggressive lymphomas. Semin Hematol 25:2-10, 1988
4. Bezwoda WR, Seymour L, Dansey RD: High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: A randomized trial [see comments]. J Clin Oncol 13:2483-2489, 1995
5. Attal M, Harousseau JL, Stoppa AM, et al: A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome. New Engl J Med 335:91-97, 1996
6. Martelli M, Vignetti M, Zinzani PL, et al: High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: A prospective randomized Italian multicenter study. J Clin Oncol 14:534-542, 1996
7. Podda S, Ward M, Himelstein A, et al: Transfer and expression of the human multiple drug resistance gene into live mice. Proc Natl Acad Sci 89:9676-9680, 1992
8. Sorrentino BP, Brandt SJ, Bodino G, et al: Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science 257:99-103, 1992
9. Ward M, Richardson C, Pioli P, et al: Transfer and expression of the human multiple drug resistance gene in human CD34+ cells. Blood 84:1408-1414, 1994
10. Hanania E, Deisseroth AB: Serial transplantation shows that early hematopoietic precursor cells are transduced by MDR-1 retroviral vector in mouse gene therapy model. Cancer Gene Ther 1:21-25, 1994
11. Ward M, Richardson C, Pioli P, et al: Transfer and expression of the human MDR gene in peripheral blood progenitor cells. Clin Cancer Res 2:873-876, 1996
12. Hesdorffer C, Antman K, Bank A, et al: Clinical protocol: Human MDR gene transfer in patients with advanced cancer. Hum Gene Ther 5:1151-1160, 1994
13. Markowitz D, Goft S, Bank A: Construction and use of a safe and efficient amphotropic packaging cell line. Virology 167:400-405, 1988
14. Pastan I, Gottesman MM, Ueda K, et al: A retrovirus carrying an MDR cDNA confers multidrug resistance and polarized expression of P-glycoprotein. Proc Natl Acad Sci 85:4486-4490, 1988
15. Lebkowski JS, Schain LR, Okrongly D, et al: Rapid isolation of human CD34 hematopoietic stem cells - purging of human tumor cells. Transplantation 53:1011-1019, 1992
16. Okarma T, Lebkowski J, Schain L, et al: The AIS Selector: A new technology for stem cell purification, in Worthington-White DA, Gee A, Gross S (eds): Advances in Bone Marrow Purging and Processing. Wiley-Liss, 1992, pp 487-504.
17. Berenson RJ, Bensinger WI, Kalamasz DF, et al: Transplantation of stem cells enriched by immunoadsorption. Prog Clin Biol Res 377:449-457, 1992
18. Berenson RJ: Transplantation of CD34+ hematopoietic precursors: Clinical rationale [review]. Transplant Proc 24:3032-3034, 1992
19. Heimfeld S, Fogarty B, McGuire K, et al: Peripheral blood stem cell mobilization after stem cell factor or G-CSF treatment: Rapid enrichment for stem and progenitor cells using the CEPRATE immunoaffinity separation system. Transplant Proc 24:2818, 1992
20. Noonan KE, Beck C, Holzmayer TA, et al: Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci 87:7160-7164, 1990
21. Aihara M, Aihara Y, Schmidt-Wolf G, et al: A combined approach for purging multidrug-resistant leukemic cell lines in bone marrow using a monoclonal antibody and chemotherapy. Blood 77:2079-2084, 1991
22. Richardson C, Bank A: Preselection of transduced murine hematopoietic stem cell populations leads to increased long-term stability and expression of the human multiple drug resistance gene. Blood 86:2579-2589, 1995
23. Lander MR, Chattopadhyay SK: A Mus dunni cell line that lacks sequences closely related to endogenous murine leukemia viruses and can be infected by ectropic, amphotropic, xenotropic, and mink cell focus-forming viruses. J Virol 52:695-698, 1984
24. Bregni M, Magni M, Siena S, et al: Human peripheral blood hematopoietic progenitors are optimal targets of retroviral-mediated gene transfer. Blood 80:1418-1422, 1992
25. Hanania EG, Giles RE, Kavanagh J, et al: Results of MDR-1 vector modification trial indicate that granulocyte-macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive chemotherapy. Proc Natl Acad Sci 93: 15346-15351, 1996
26. Peters SO, Kittler EL, Ramshaw HS, et al: Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. Blood 87:30-37, 1996
27. Zandstra PW, Conneally E, Piret JM, et al: Normal bone marrow cells capable of generating expanded populations of LTC-IC are CD34+CD38-, require particularly high concentrations of flt3-ligand (FL) and are inhibited by excess IL-3. Blood 88:445a, 1996 (abstr)
28. Yonemura Y, Ku H, Lyman SD, et al: In vitro expansion of hematopoietic progenitors and maintenance of stem cells: Comparison between flt3/flk2 ligand and kit ligand. Blood 89:1915-1921, 1997
29. Trevisan M, Yan XQ, Iscove NN: Cycle intiation and colony formation in culture by murine marrow cells with long-term reconstituting potential in vivo. Blood 88:4149-4158, 1996
30. Borge OJ, Ramsfjell V, Veiby OP, et al: Thromobpoietin, but not erythropoietin promotes viability and inhibits apoptosis of multipotent murine hematopoietic progenitor cells in vitro. Blood 88:2859-2870, 1996
31. Conneally E, Cashman J, Petzer AL, et al: In vitro expansion of human lympho-myeloid stem cells from cord blood demonstrated using a quantitative in vivo repopulating assay. Blood 88:628a, 1996 (abstr)
32. Conneally E, Eaves CJ, Humphries RK: High efficiency gene transfer to primitive human hematopoietic stem cells capable of multilineage repopulation of immunodeficient NOD/SCID mice. Blood 88:646a, 1996 (abstr)